Scott C. Bresler, Ph.D.
Affiliations: | 2011 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Biochemistry, General BiophysicsGoogle:
"Scott Bresler"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Mark A. Lemmon | grad student | 2011 | Penn | |
| (Regulation and inhibition of the anaplastic lymphoma kinase.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zahn J, Chan MP, Wang G, et al. (2019) Altered RB, p16, or p53 expression is specific for porocarcinoma relative to poroma. Journal of Cutaneous Pathology |
| Bresler SC, Min L, Rodig SJ, et al. (2016) Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunity. Laboratory Investigation; a Journal of Technical Methods and Pathology |
| Bresler SC, Padwa BL, Granter SR. (2016) Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome). Head and Neck Pathology |
| Bresler SC, Weiser DA, Huwe PJ, et al. (2014) ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma. Cancer Cell. 26: 682-94 |
| Huwe PJ, Bresler S, Park J, et al. (2013) Understanding Kinase Activation of ALK in Neuroblastoma Patients Biophysical Journal. 104: 662a |
| Carpenter EL, Haglund EA, Mace EM, et al. (2012) Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma. Oncogene. 31: 4859-67 |
| Carpenter EL, Haglund EA, Mace EM, et al. (2012) Erratum: Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastoma Oncogene. 31: 4888-4888 |
| Bresler SC, Wood AC, Haglund EA, et al. (2011) Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma. Science Translational Medicine. 3: 108ra114 |
| Bresler SC, Wood A, Haglund E, et al. (2011) Abstract 4685: Mechanistic guidance of ALK inhibition for the treatment of neuroblastoma Cancer Research. 71: 4685-4685 |